Evommune, Inc.: shareholders and insiders

EVMNNYSEHealthcare · Pharmaceutical Preparations

Price

$7.04

November 20, 2026Market cap $291M

What Ploutos Investor adds for Evommune

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

5 Holders over 5%2 On a 13DNov 10, 2026 Latest filing
  • LSP 7 Cooperatieve U.A.with 1 more person
    Share of class14.7%
  • Nan Fung Group Holdings Limitedwith 12 more persons
    Share of class10.9%
  • RA Capital Management, L.P.with 3 more persons
    Share of class8.50%
  • T. Rowe Price Associates, Inc.
    Share of class5.40%
  • Point72 Asset Management, L.P.with 2 more persons
    Share of class5.30%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • LSP 7 Cooperatieve U.A.14.7%From the filing of Nov 14, 2025

    Third Amended and Restated Investors' Rights Agreement On October 30, 2024, certain investors of the Issuer, including LSP 7, entered into a third amended and restated investors' right agreement (the "Investors' Rights Agreement") with the Issuer, pursuant to which the Issuer agreed to register for resale certain shares of Common Stock and other equity securities of the Issuer that are held by the parties (the "Registrable Securities"), and agreed to provide customary "piggyback" registration rights, subject to certain requirements and conditions. Pursuant to the Investors' Rights Agreement, beginning 180 days after the effective date of the registration statement filed in connection with…

    From the filing of Nov 14, 2025
  • RA Capital Management, L.P.8.5%From the filing of Nov 17, 2025

    The Reporting Persons acquired the common stock reported herein for investment purposes and not with an intent, purpose or effect of changing control of the Issuer. Although the Reporting Persons currently have no plan or proposal to acquire any additional Issuer securities or to dispose of any of the Issuer securities reported herein, the Reporting Persons may, from time to time, acquire additional equity securities or debt securities of the Issuer, which debt securities may be convertible or non-convertible, secured or unsecured, and could involve the monetization of potential revenue streams deriving from development-stage or commercial programs of the Issuer, or dispose of Issuer…

    From the filing of Nov 17, 2025
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Andera Partners3.90%Aug 14, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter+70%
  • Millennium Mgmt (Englander)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter×35.4
  • D.E. Shaw
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 8.54% of its shares outstanding were held short, +22.1% since the report before.

Shares held short
3.53M
8.54%
Since the report before2.89M on Sep 30, 2026
+22.1%
3.4
1.03M
More days to cover thanof 4,578 US-listed companies with enough volume
40%
Report date
Oct 15, 2026
  • Nov 14, 2025: Shares held short 102.8K
  • Nov 28, 2025: Shares held short 111.8K
  • Dec 15, 2025: Shares held short 479.1K
  • Dec 31, 2025: Shares held short 1.04M
  • Jan 15, 2026: Shares held short 1.90M
  • Jan 30, 2026: Shares held short 2.51M
  • Feb 13, 2026: Shares held short 2.83M
  • Feb 27, 2026: Shares held short 3.03M
  • Mar 13, 2026: Shares held short 3.06M
  • Mar 31, 2026: Shares held short 3.31M
  • Apr 15, 2026: Shares held short 3.46M
  • Apr 30, 2026: Shares held short 3.25M
  • May 15, 2026: Shares held short 3.10M
  • May 29, 2026: Shares held short 3.98M
  • Jun 15, 2026: Shares held short 4.27M
  • Jun 30, 2026: Shares held short 4.78M
  • Jul 15, 2026: Shares held short 4.02M
  • Jul 31, 2026: Shares held short 4.48M
  • Aug 14, 2026: Shares held short 4.70M
  • Aug 31, 2026: Shares held short 4.36M
  • Sep 15, 2026: Shares held short 2.88M
  • Sep 30, 2026: Shares held short 2.89M
  • Oct 15, 2026: Shares held short 3.53M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading55.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 55.5% of the shares in the reported trades were short sales, against 50.5% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
55.5%
The 14 beforeOct 14, 2026 – Nov 2, 2026
50.5%
Change
+5.0 pts
Short sales a dayon average, of 246.7K shares
136.9K
More than atof 3,666 US-listed companies, same days
69%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 43.8%
  • Oct 15, 2026: Short sales 57.9%
  • Oct 16, 2026: Short sales 55.8%
  • Oct 19, 2026: Short sales 42.3%
  • Oct 20, 2026: Short sales 44.1%
  • Oct 21, 2026: Short sales 37%
  • Oct 22, 2026: Short sales 39.1%
  • Oct 23, 2026: Short sales 48%
  • Oct 26, 2026: Short sales 53.8%
  • Oct 27, 2026: Short sales 56.9%
  • Oct 28, 2026: Short sales 52%
  • Oct 29, 2026: Short sales 43.8%
  • Oct 30, 2026: Short sales 42.8%
  • Nov 2, 2026: Short sales 54.1%
  • Nov 3, 2026: Short sales 44.1%
  • Nov 4, 2026: Short sales 44.8%
  • Nov 5, 2026: Short sales 46.9%
  • Nov 6, 2026: Short sales 32%
  • Nov 9, 2026: Short sales 45%
  • Nov 10, 2026: Short sales 36.6%
  • Nov 11, 2026: Short sales 50.6%
  • Nov 12, 2026: Short sales 63.2%
  • Nov 13, 2026: Short sales 54.2%
  • Nov 16, 2026: Short sales 77.9%
  • Nov 17, 2026: Short sales 79.6%
  • Nov 18, 2026: Short sales 65%
  • Nov 19, 2026: Short sales 47.8%
  • Nov 20, 2026: Short sales 60.6%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

9 ETFs holding it0.04% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.04%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.00%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • SCHBSchwab U.S. Broad Market ETF
    Weight in the fund0.00%

9 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

105 Managers, Q2 2026$463M Value of their positions
  • Q4 2025: Managers 59
  • Q1 2026: Managers 84
  • Q2 2026: Managers 105

Q2 2026: 105 managers held 34.64M shares, worth $463M. During the quarter 40 opened a position, 20 closed one, 34 added and 13 trimmed.

The largest holders, Q2 2026

  • EQT Fund Management S.a r.l.
    In the quarter+7.3%
  • Ra Capital Management
    In the quarter
  • Price T Rowe Associates
    In the quarter+73%
  • Pivotal bioVenture Partners Investment Advisor
    In the quarter
  • JPMorgan Chase
    In the quarter+6.4%
  • Rtw Investments
    In the quarter
  • Nan Fung Group Holdings
    In the quarter
  • Point72 (Cohen)
    In the quarter×39.2
  • Andera Partners
    In the quarter-27%
  • Eventide Asset Management
    In the quarter

From the SEC's Form 13F data sets, Q4 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Evommune's filings show?

Who buys and sells is one part of Evommune's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about EVMN's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold EVMN?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Point72 (Cohen)'s, worth $20M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.